生物數據可視化市場規模、份額和趨勢分析報告：按技術（顯微鏡、測序）、應用（系統生物學）、平台、最終用途、地區、細分市場預測，2022-2030 年

生物數據可視化市場增長及趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球生物數據可視化市場預計將達到 13 億美元。從 2022 年到 2030 年，該市場預計將以 12.0% 的複合年增長率增長。基因組學和蛋白□□質組學研究的興起是主要的市場驅動力之一。市場參與者正專注於新產品發布、併購和技術合作等戰略舉措，以增加他們在生物數據可視化市場的份額。例如，2021 年 8 月，DNAnexus, Inc. 宣布其生物醫學信息學平台標準超出了美國政府最近一項行政命令中規定的在線安全政策目標。這讓NGS終端用戶對產品更有信心，並幫助他們以高安全性管理大規模生物醫學信息。

生命科學研究人員和從業人員依靠可視化技術來解決理解和解釋生物信息方面的各種挑戰。原始計算和圖形處理能力的快速發展促進了生物信息在多功能桌面平台上的可視化。此外，越來越多地採用下一代測序 (NGS) 技術和其他生物數據採集方法，生成新型數據集，增加了研究人員和科學家對可視化工具的需求。

例如，西班牙已成為 NGS 數據分析極具吸引力和競爭性的市場。 2020 年 9 月，西班牙政府撥款 2950 萬美元用於精準醫學和基因組醫學以及數據科學。該投資旨在利用科學知識作為增強該地區衛生系統能力的工具，並通過促進創新使其在經濟上具有競爭力。兩年（2020-22）的撥款總額為 8933 萬美元。投資類別包括基因組醫學、大數據健康、預測醫學、先進和個性化醫學以及精準醫學培訓。

COVID-19 大流行增加了序列信息分析平台的使用，這些平台在病毒檢測和跟蹤方面發揮著重要作用，支持生物數據可視化市場的增長。部署了各種序列監控平台和解決方案，以有效診斷感染。此外，主要利益相關者正在採取一系列戰略舉措，包括合作和聯合研究許可，以抗擊這種疾病。例如，2021 年 2 月，加拿大政府投資 5300 萬美元實施多層次方法診斷 COVID-19。加拿大政府計劃利用基因組測序技術來達到預期的效果。

分析和商業智能解決方案的技術進步、大數據的快速增長以及對更快決策制定的日益增長的需求是推動生物信息學領域對可視化工具需求的其他一些因素。大量的高維生物信息需要機器學習和先進的數據可視化方法才能被人類專家輕鬆理解。

另一方面，生物數據可視化市場具有分散性，有大量公司，從大型全球參與者到較小的本地或區域參與者。市場上的主要供應商包括 QIAGEN、Thermo Fisher Scientific Inc.、Agilent Technologies, Inc.、Becton-Dickinson and Company 和 3M。

生物數據可視化市場報告亮點

從技術來看，測序預計將在 2021 年佔據很大份額。測序產生的大量信息需要數據管理解決方案和平台，導致對生物研究工具和算法的高需求。

按應用來看，基因組分析領域有望在 2021 年佔據生物數據可視化市場的很大份額。某些因素，例如增加對新平台開發的投資、積極採用分析解決方案以及技術創新，正在推動該應用中新產品的推出。

按平台劃分，Mac OS 有望在生物數據可視化市場中增長最快。該操作系統設計為用戶友好且簡單，並具有許多安全功能來保護您的信息。

從最終用戶來看，學術研究領域預計將在 2021 年佔據大部分市場份額。這是由於在研究和數據可視化工具的實施過程中使用了下一代測序 (NGS) 和 X 射線晶體學技術。因此，在這些設施中越來越多地實施此類技術將推動對可視化工具的需求，以準確觀察生物學研究中的研究結果。

由於主要公司在該地區的存在以及與基因組學和系統生物學相關的大量研究項目，北美將在 2021 年成為生物數據可視化的區域市場。

內容

第 1 章研究方法論

• 按國家/地區劃分的市場：基本估計
• 全球市場：CAGR 計算
• 按地區計算細分市場份額
• 調查範圍和假設
• 數據源列表
  • 來自主要訪談的數據（按來源）
  • 按地區劃分的首次訪談數據

第 2 章執行摘要

• 市場概況

第 3 章生物數據可視化市場變量、趨勢和範圍

• 市場系列展望
• 市場動態
  • 市場促進因素分析
    • 生物數據的快速增長
    • 將人工智能融入生物數據分析
    • 對更快決策的需求不斷增加
  • 市場抑制因素分析
    • 數據可視化帶來的用戶界面挑戰
    • 數據管理計算缺乏一致性
• 2021 年應用程序滲透率和增長前景圖
• 生物識別數據可視化市場 - SWOT 分析，按因素（政治與法律、經濟與技術）
• 行業分析 - 搬運工
• 對主要交易和戰略聯盟的分析
  • 產品開發
  • 併購
  • 合作與夥伴關係
  • 協議
• 市場進入策略
• COVID-19 影響分析

第 4 章生物數據可視化市場分類：技術估計和趨勢分析

• 市場：技術波動分析，2021 年和 2030 年
• 顯微鏡
• 磁共振成像
• 測序
• X射線晶體學
• 其他

第 5 章生物數據可視化市場分類：應用估計和趨勢分析

• 生物數據可視化市場：應用變化分析，2021 年和 2030 年
• 成像細胞和生物體
• 結構生物學和分子建模
• 基因組分析
• 對齊、系統發育和進化
• 系統生物學

第 6 章生物數據可視化市場分類：平台估計和趨勢分析

• 生物數據可視化市場：平台波動分析，2021 年和 2030 年
• WINDOWS
• 蘋果操作系統
• Linux
• 其他

第 7 章生物數據可視化市場分類：最終用途估計和趨勢分析

• 市場：最終用途變化分析，2021 年和 2030 年
• 學術研究
• 醫院和診所
• 製藥和生物技術公司
• 其他

第 8 章生物數據可視化市場分類：按技術、應用、平台和最終用途的區域估計和趨勢分析

• 生物數據可視化市場：區域差異分析，2021 年和 2030 年
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 韓國
  • 澳大利亞
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲 (MEA)
  • 南非
  • 沙特阿拉伯
  • 阿拉伯聯合酋長國

第 9 章競爭格局

• 戰略框架
• 市場參與分類
• 主要市場進入者的近期趨勢和影響分析
• 上市公司
  • 繪製知名行業參與者的滲透率和增長前景，2021 年
• 私人公司
  • 主要初創公司名單
• 公司簡介
  • 3M
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Thermo Fisher Scientific, Inc.
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Tableau Software, LLC
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Agilent Technologies Inc.
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • QIAGEN
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • ZEISS International
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Oxford Instruments
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Olympus Corporation
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Clarivate
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • General Electric Company
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措

Biological Data Visualization Market Growth & Trends:

The global biological data visualization market size is expected to reach USD 1.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.0% from 2022 to 2030. The growing research in genomics and proteomics is one of the major market drivers. Major companies in the market are focusing on strategic initiatives such as new product launches, mergers and acquisitions, and technological collaborations, to increase their share in the biological data visualization market. For instance, in August 2021, DNAnexus, Inc. announced that the standards of the biomedical informatics platform outperformed the online security policy objectives outlined in the U.S. Government's recent executive order. This helped build confidence in the product among NGS end-users and assisted in managing large biomedical information with high security.

The life-science researchers and practitioners rely on visualization techniques for solving a wide range of challenges in understanding and interpreting biological information. Rapid advancements in raw computing power and graphics processing power make visualization of biological information easier on commodity desktop platforms. Besides, the increase in the adoption Of Next-Generation Sequencing (NGS) techniques and other biological data-acquisition approaches, which generate new types and sets of data, necessitates the demand for visualization tools among researchers and scientists.

For instance, Spain has become an attractive and competitive market for NGS data analysis. In September 2020, the Government of Spain allocated USD 29.5 million for precision and genomic medicine, and data science. This investment aims to enhance the capacity of the regional health system and use scientific knowledge as a tool to embrace economic competitiveness by contributing to innovation. The total funds allocated for 2 years (2020-22) is USD 89.33 million. The segment of investment includes genomic medicine, big data health, predictive medicine, advanced and personalized therapy, and precision medicine training.

The COVID-19 pandemic resulted in increased usage of sequencing information analysis platform plays a crucial role in the detection and tracing of the virus and support the growth of the biological data visualization market. Various sequencing surveillance platforms and solutions are being deployed for the effective diagnosis of infection. Furthermore, key stakeholders are undertaking various strategic initiatives, such as collaborations and licensing for collaborative efforts, to combat the disease. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach to the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

Technological advancements in analytical and business intelligence solutions coupled with rapid growth in big data and the rise in the need for faster decision-making are a few other drivers boosting the demand for visualization tools in the bioinformatics field. The sheer amount of high-dimensional biological information needs machine learning and advanced data visualization approaches so that it can be easily understandable by human experts.

On the other hand, the biological data visualization market is fragmented in nature with a substantial number of companies ranging from large global players to small mid-sized local or regional players. Some of the public key vendors operating in the market include QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Becton-Dickinson and Company, and 3M.

Biological Data Visualization Market Report Highlights:

• By technique, sequencing is estimated to have a major market share in 2021. The large amount of information generated through sequencing needs data management solutions and platforms, resulting in high demand for tools & algorithms for biological research.

• By application, the genomic analysis segment is anticipated to have a significant share of the biological data visualization market in 2021. Certain factors such as increasing investment for the development of new platforms, a positive approach toward the adoption of analytical solutions, and technological innovations are leveraging new product launches in this application.

• By platform, Mac OS is anticipated to be the fastest-growing segment in the biological data visualization market. Since the operating system has a user-friendly and simple design with better in-built security features for protecting information.

• By end-user, the academic research segment is estimated to have a majority of the market share in 2021. This is attributed to the use of next-generation sequencing (NGS), and X-ray crystallography methods during their research to implement data visualization tools. Thus, an increase in the implementation of such techniques in these facilities drives the demand for visualization tools to precisely observe their research findings in biological research.

• North America is considered to be a dominating regional market for biological data visualization in 2021 owing to the local presence of key players in the region and a significant number of research projects related to genomic analysis and systems biology.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Country Wise Market: Base Estimates
• 1.2 Global Market: CAGR Calculation
• 1.3 Region-Based Segment Share Calculation
• 1.4 Research Scope & Assumptions
• 1.5 List of Data Sources
  • 1.5.1 Data for primary interviews, by sources
  • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

• 2.1 Market Snapshot

Chapter 3 Biological Data Visualization Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market driver analysis
    • 3.2.1.1 Rapid growth of biological data
    • 3.2.1.2 Incorporation of artificial intelligence in analysis of biological data
    • 3.2.1.3 Growing demand for faster decision making
  • 3.2.2 Market restraint analysis
    • 3.2.2.1 User- interface challenges pertaining to data visualization
    • 3.2.2.2 Lack of computational consistency for data management
• 3.3 Penetration & Growth Prospect Mapping for Application, 2021
• 3.4 Biological Data Visualization Market-SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• 3.5 Industry Analysis - Porter's
• 3.6 Major Deals & Strategic Alliances Analysis
  • 3.6.1 Product developments
  • 3.6.2 Merger & acquisition
  • 3.6.3 Collaboration & partnership
  • 3.6.4 Agreement
• 3.7 Market Entry Strategies
• 3.8 COVID-19 Impact Analysis

Chapter 4 Biological Data Visualization Market Categorization: Technique Estimates & Trend Analysis

• 4.1 Market: Technique Movement Analysis, 2021 & 2030
• 4.2 Microscopy
  • 4.2.1 Microscopy Market, 2018 - 2030 (USD Million)
• 4.3 Magnetic Resonance Imaging
  • 4.3.1 MRI Market, 2018 - 2030 (USD Million)
• 4.4 Sequencing
  • 4.4.1 Sequencing Market, 2018 - 2030 (USD Million)
• 4.5 X-ray Crystallography
  • 4.5.1 X-ray crystallography Market, 2018 - 2030 (USD Million)
• 4.6 Others
  • 4.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Biological Data Visualization Market Categorization: Application Estimates & Trend Analysis

• 5.1 Biological Data Visualization Market: Application Movement Analysis, 2021 & 2030
• 5.2 Cell and Organism Imaging
  • 5.2.1 Cell and Organism Imaging Market, 2018 - 2030 (USD Million)
• 5.3 Structural Biology and Molecular Modeling
  • 5.3.1 Structural Biology and Molecular Modeling Market, 2018 - 2030 (USD Million)
• 5.4 Genomic Analysis
  • 5.4.1 Genomic Analysis Market, 2018 - 2030 (USD Million)
• 5.5 Alignments, Phylogeny, and Evolution
  • 5.5.1 Alignments, Phylogeny, And Evolution Market, 2018 - 2030 (USD Million)
• 5.6 Systems Biology
  • 5.6.1 Systems Biology Market, 2018 - 2030 (USD Million)

Chapter 6 Biological Data Visualization Market Categorization: Platform Estimates & Trend Analysis

• 6.1 Biological Data Visualization Market: Platform Movement Analysis, 2021 & 2030
• 6.2 Windows
  • 6.2.1 Windows Market, 2018 - 2030 (USD Million)
• 6.3 MAC OS
  • 6.3.1 MAC OS Market, 2018 - 2030 (USD Million)
• 6.4 Linux
  • 6.4.1 Linux Market, 2018 - 2030 (USD Million)
• 6.5 Others
  • 6.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Biological Data Visualization Market Categorization: End-use Estimates & Trend Analysis

• 7.1 Market: End-use Movement Analysis, 2021 & 2030
• 7.2 Academic Research
  • 7.2.1 Academic Research Market, 2018 - 2030 (USD Million)
• 7.3 Hospitals & Clinics
  • 7.3.1 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 7.4 Pharmaceutical & Biotechnology Companies
  • 7.4.1 Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 7.5 Others
  • 7.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Biological Data Visualization Market Categorization: Regional Estimates & Trend Analysis, by Technique, Application, Platform, & End-use

• 8.1 Biological Data Visualization Market: Regional Movement Analysis, 2021 & 2030
• 8.2 North America
  • 8.2.1 North America biological data visualization market, by technique, 2018 - 2030 (USD Million)
  • 8.2.2 North America biological data visualization market, by application, 2018 - 2030 (USD Million)
  • 8.2.3 North America biological data visualization market, by platform, 2018 - 2030 (USD Million)
  • 8.2.4 North America biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.2.5 U.S.
    • 8.2.5.1 U.S. biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.2.5.2 U.S. biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.2.5.3 U.S. biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.2.5.4 U.S. biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.2.6 Canada
    • 8.2.6.1 Canada biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.2.6.2 Canada biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.2.6.3 Canada biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.2.6.4 Canada biological data visualization market, by end-use, 2018 - 2030 (USD Million)
• 8.3 Europe
  • 8.3.1 Europe biological data visualization market, by technique, 2018 - 2030 (USD Million)
  • 8.3.2 Europe biological data visualization market, by application, 2018 - 2030 (USD Million)
  • 8.3.3 Europe biological data visualization market, by platform, 2018 - 2030 (USD Million)
  • 8.3.4 Europe biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.3.5 Germany
    • 8.3.5.1 Germany biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.3.5.2 Germany biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.3.5.3 Germany biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.3.5.4 Germany biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.3.6 U.K.
    • 8.3.6.1 U.K. biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.3.6.2 U.K. biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.3.6.3 U.K. biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.3.6.4 U.K. biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.3.7 France
    • 8.3.7.1 France biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.3.7.2 France biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.3.7.3 France biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.3.7.4 France biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.3.8 Italy
    • 8.3.8.1 Italy biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.3.8.2 Italy biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.3.8.3 Italy biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.3.8.4 Italy biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.3.9 Spain
    • 8.3.9.1 Spain biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.3.9.2 Spain biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.3.9.3 Spain biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.3.9.4 Spain biological data visualization market, by end-use, 2018 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific biological data visualization market, 2018 - 2030 (USD Million)
  • 8.4.2 Asia Pacific biological data visualization market, by application, 2018 - 2030 (USD Million)
  • 8.4.3 Asia Pacific biological data visualization market, by platform, 2018 - 2030 (USD Million)
  • 8.4.4 Asia Pacific biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.4.5 Japan
    • 8.4.5.1 Japan biological data visualization market, 2018 - 2030 (USD Million)
    • 8.4.5.2 Japan biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.4.5.3 Japan biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.4.5.4 Japan biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.4.6 China
    • 8.4.6.1 China biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.4.6.2 China biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.4.6.3 China biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.4.6.4 China biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.4.7 India
    • 8.4.7.1 India biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.4.7.2 India biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.4.7.3 India biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.4.7.4 India biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.4.8 South Korea
    • 8.4.8.1 South Korea biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.4.8.2 South Korea biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.4.8.3 South Korea biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.4.8.4 South Korea biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.4.9 Australia
    • 8.4.9.1 Australia biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.4.9.2 Australia biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.4.9.3 Australia biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.4.9.4 Australia biological data visualization market, by end-use, 2018 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Latin America biological data visualization market, by technique, 2018 - 2030 (USD Million)
  • 8.5.2 Latin America biological data visualization market, by application, 2018 - 2030 (USD Million)
  • 8.5.3 Latin America biological data visualization market, by platform, 2018 - 2030 (USD Million)
  • 8.5.4 Latin America biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.5.5 Brazil
    • 8.5.5.1 Brazil biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.5.5.2 Brazil biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.5.5.3 Brazil biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.5.5.4 Brazil biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.5.6 Mexico
    • 8.5.6.1 Mexico biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.5.6.2 Mexico biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.5.6.3 Mexico biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.5.6.4 Mexico biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.5.7 Argentina
    • 8.5.7.1 Argentina biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.5.7.2 Argentina biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.5.7.3 Argentina biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.5.7.4 Argentina biological data visualization market, by end-use, 2018 - 2030 (USD Million)
• 8.6 Middle East and Africa (MEA)
  • 8.6.1 MEA biological data visualization market, by technique, 2018 - 2030 (USD Million)
  • 8.6.2 MEA biological data visualization market, by application, 2018 - 2030 (USD Million)
  • 8.6.3 MEA biological data visualization market, by platform, 2018 - 2030 (USD Million)
  • 8.6.4 MEA biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.6.5 South Africa
    • 8.6.5.1 South Africa biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.6.5.2 South Africa biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.6.5.3 South Africa biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.6.5.4 South Africa biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.6.6 Saudi Arabia
    • 8.6.6.1 Saudi Arabia biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.6.6.2 Saudi Arabia biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.6.6.3 Saudi Arabia biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.6.6.4 Saudi Arabia biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.6.7 UAE
    • 8.6.7.1 UAE biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.6.7.2 UAE biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.6.7.3 UAE biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.6.7.4 UAE biological data visualization market, by end-use, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

• 9.1 Strategy Framework
• 9.2 Market Participation Categorization
• 9.3 Recent Developments & Impact Analysis, by Key Market Participants
• 9.4 Public Companies
  • 9.4.1 Penetration & growth prospect mapping for prominent industry players, 2021
• 9.5 Private Companies
  • 9.5.1 List of key emerging companies
• 9.6 Company Profiles
  • 9.6.1 3M
    • 9.6.1.1 Company overview
    • 9.6.1.2 Financial performance
    • 9.6.1.3 Product benchmarking
    • 9.6.1.4 Strategic initiatives
  • 9.6.2 Thermo Fisher Scientific, Inc.
    • 9.6.2.1 Company overview
    • 9.6.2.2 Financial performance
    • 9.6.2.3 Product benchmarking
    • 9.6.2.4 Strategic initiatives
  • 9.6.3 Tableau Software, LLC
    • 9.6.3.1 Company overview
    • 9.6.3.2 Financial performance
    • 9.6.3.3 Product benchmarking
    • 9.6.3.4 Strategic initiatives
  • 9.6.4 Agilent Technologies Inc.
    • 9.6.4.1 Company overview
    • 9.6.4.2 Financial performance
    • 9.6.4.3 Product benchmarking
    • 9.6.4.4 Strategic initiatives
  • 9.6.5 QIAGEN
    • 9.6.5.1 Company overview
    • 9.6.5.2 Financial performance
    • 9.6.5.3 Product benchmarking
    • 9.6.5.4 Strategic initiatives
  • 9.6.6 ZEISS International
    • 9.6.6.1 Company overview
    • 9.6.6.2 Financial performance
    • 9.6.6.3 Product benchmarking
    • 9.6.6.4 Strategic initiatives
  • 9.6.7 Oxford Instruments
    • 9.6.7.1 Company overview
    • 9.6.7.2 Financial performance
    • 9.6.7.3 Product benchmarking
    • 9.6.7.4 Strategic initiatives
  • 9.6.8 Olympus Corporation
    • 9.6.8.1 Company overview
    • 9.6.8.2 Financial performance
    • 9.6.8.3 Product benchmarking
    • 9.6.8.4 Strategic initiatives
  • 9.6.9 Clarivate
    • 9.6.9.1 Company overview
    • 9.6.9.2 Financial performance
    • 9.6.9.3 Product benchmarking
    • 9.6.9.4 Strategic initiatives
  • 9.6.10 General Electric Company
    • 9.6.10.1 Company overview
    • 9.6.10.2 Financial performance
    • 9.6.10.3 Product benchmarking
    • 9.6.10.4 Strategic initiatives

List of Tables

• TABLE 1 List of Secondary Sources
• TABLE 2 List of Abbreviations
• TABLE 3 Global Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 4 Global Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 5 Global Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 6 Global Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 7 Global Biological Data Visualization, by Region, 2018 - 2030 (USD Million)
• TABLE 8 North America Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
• TABLE 9 North America Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 10 North America Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 11 North America Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 12 North America Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 13 U.S. Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 14 U.S. Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 15 U.S. Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 16 U.S. Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 17 Canada Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 18 Canada Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 19 Canada Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 20 Canada Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 21 Europe Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
• TABLE 22 Europe Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 23 Europe Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 24 Europe Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 25 Europe Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 26 Germany Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 27 Germany Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 28 Germany Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 29 Germany Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 30 U.K. Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 31 U.K. Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 32 U.K. Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 33 U.K. Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 34 France Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 35 France Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 36 France Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 37 France Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 38 Italy Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 39 Italy Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 40 Italy Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 41 Italy Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 42 Spain Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 43 Spain Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 44 Spain Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 45 Spain Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 46 Asia Pacific Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
• TABLE 47 Asia Pacific Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 48 Asia Pacific Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 49 Asia Pacific Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 50 Asia Pacific Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 51 China Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 52 China Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 53 China Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 54 China Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 55 Japan Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 56 Japan Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 57 Japan Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 58 Japan Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 59 India Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 60 India Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 61 India Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 62 India Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 63 South Korea Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 64 South Korea Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 65 South Korea Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 66 South Korea Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 67 Australia Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 68 Australia Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 69 Australia Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 70 Australia Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 71 Latin America Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
• TABLE 72 Latin America Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 73 Latin America Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 74 Latin America Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 75 Latin America Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 76 Brazil Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 77 Brazil Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 78 Brazil Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 79 Brazil Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 80 Mexico Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 81 Mexico Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 82 Mexico Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 83 Mexico Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 84 Argentina Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 85 Argentina Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 86 Argentina Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 87 Argentina Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 88 Middle East & Africa Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
• TABLE 89 Middle East & Africa Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 90 Middle East & Africa Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 91 Middle East & Africa Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 92 Middle East & Africa Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 93 South Africa Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 94 South Africa Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 95 South Africa Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 96 South Africa Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 97 Saudi Arabia Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 98 Saudi Arabia Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 99 Saudi Arabia Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 100 Saudi Arabia Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
• TABLE 101 UAE Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
• TABLE 102 UAE Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
• TABLE 103 UAE Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
• TABLE 104 UAE Biological Data Visualization, End-use, 2018 - 2030 (USD Million)

List of Figures

• FIG. 1 Market research process
• FIG. 2 Information Procurement
• FIG. 3 Primary Research Pattern
• FIG. 4 Market Research Approaches
• FIG. 5 Value Chain-Based Sizing & Forecasting
• FIG. 6 Market Formulation & Validation
• FIG. 7 Biological Data Visualization, Market Segmentation
• FIG. 8 Market Snapshot, 2021
• FIG. 9 Market Trends & Outlook
• FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
• FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• FIG. 14 Porter's Five Forces Analysis
• FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
• FIG. 16 Global Biological Data Visualization: Technique Movement Analysis
• FIG. 17 Global Biological Data Visualization, for Microscopy, 2018 - 2030 (USD Million)
• FIG. 18 Global Biological Data Visualization, for MAGNETIC resonance imaging, 2018 - 2030 (USD Million)
• FIG. 19 Global Biological Data Visualization, for Sequencing, 2018 - 2030 (USD Million)
• FIG. 20 Global Biological Data Visualization, for X-ray Crystallography, 2018 - 2030 (USD Million)
• FIG. 21 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
• FIG. 22 Global Biological Data Visualization: Application Movement Analysis
• FIG. 23 Global Biological Data Visualization, for Cell and Organism Imaging, 2018 - 2030 (USD Million)
• FIG. 24 Global Biological Data Visualization, for Structural biology and Molecular Modeling, 2018 - 2030 (USD Million)
• FIG. 25 Global Biological Data Visualization, for Genomic Analysis, 2018 - 2030 (USD Million)
• FIG. 26 Global Biological Data Visualization, for Alignments, phylogeny, and Evolution, 2018 - 2030 (USD Million)
• FIG. 27 Global Biological Data Visualization, for Systems Biology, 2018 - 2030 (USD Million)
• FIG. 28 Global Biological Data Visualization: Platform Movement Analysis
• FIG. 29 Global Biological Data Visualization, for Windows, 2018 - 2030 (USD Million)
• FIG. 30 Global Biological Data Visualization, for Mac OS, 2018 - 2030 (USD Million)
• FIG. 31 Global Biological Data Visualization, for Linux, 2018 - 2030 (USD Million)
• FIG. 32 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
• FIG. 33 Global Biological Data Visualization: End-Use Movement Analysis
• FIG. 34 Global Biological Data Visualization, for Academic Institutes & Research Centers, 2018 - 2030 (USD Million)
• FIG. 35 Global Biological Data Visualization, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
• FIG. 36 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
• FIG. 37 Regional Marketplace: Key Takeaways
• FIG. 38 Regional Outlook, 2021 & 2030
• FIG. 39 Global Biological Data Visualization: Region Movement Analysis
• FIG. 40 North America Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 41 U.S. Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 42 Canada Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 43 Europe Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 44 Germany Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 45 U.K. Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 46 France Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 47 Italy Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 48 Spain Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 49 Asia Pacific Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 50 Japan Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 51 China Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 52 India Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 53 Australia Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 54 South Korea Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 55 Latin America Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 56 Brazil Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 57 Mexico Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 58 Argentina Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 59 Middle East and Africa Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 60 South Africa Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 61 Saudi Arabia Biological Data Visualization, 2018 - 2030 (USD Million)
• FIG. 62 UAE Biological Data Visualization, 2018 - 2030 (USD Million)